Clinical Trial Update: The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older Adults [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated whether a selective serotonin reuptake inhibitor affects gait, balance, and bone metabolism in older adults with depression. The trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Selective serotonin reuptake inhibitor (selective serotonin reuptake inhibitor)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Depression | Phase 4 | Status: COMPLETED